메뉴 건너뛰기




Volumn 3, Issue 2, 1996, Pages 83-88

Prodrug-activated gene therapy: Involvement of an immunological component in the "bystander effect"

Author keywords

Bystander effect; Immunological component; Prodrug activated gene therapy

Indexed keywords

GANCICLOVIR; PRODRUG; THYMIDINE KINASE;

EID: 0030100158     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (147)

References (3)
  • 1
    • 0026772206 scopus 로고
    • In vivo gene transfer with retroviral vectorproducer cells for treatment of experimental brain tumours
    • Culver KV, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vectorproducer cells for treatment of experimental brain tumours. Science. 1992;256:1550-1552.
    • (1992) Science , vol.256 , pp. 1550-1552
    • Culver, K.V.1    Ram, Z.2    Wallbridge, S.3    Ishii, H.4    Oldfield, E.H.5    Blaese, R.M.6
  • 3
    • 0028297316 scopus 로고
    • Tumours expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumour
    • Mullen CA, Coale MM, Lowe R, Blaese RM. Tumours expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumour. Cancer Res. 1994;54:1503-1506.
    • (1994) Cancer Res. , vol.54 , pp. 1503-1506
    • Mullen, C.A.1    Coale, M.M.2    Lowe, R.3    Blaese, R.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.